Episode 6: The Changing Treatment Paradigm of HER2+ Metastatic Breast Cancer

Novel Treatment Approaches to R/R HER2+ Metastatic Breast Cancer

Dr. VK Gadi leads experts in discussing the role of novel therapies in relapsed/refractory HER2+ metastatic breast cancer accounting for results from a recent clinical trial.

The University of Illinois Cancer Center serves as a Strategic Alliance Partner with OncLive. View our complete video library.

Translate »